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Abstract
Background: Bladder exstrophy occurs in approximately 1 in 35,000 live births and is associated with an increased
incidence of bladder cancer.
The primary mucinous adenocarcinoma of the bladder is an extremely rare urologic entity, which is found in less
than 2% of all urinary bladder tumours and is often presented as metastatic. This is the first case in literature of a
primary mucinous adenocarcinoma of an unreconstructed exstrophic bladder.
Case presentation: A 55-year old male patient was diagnosed with a primary mucinous adenocarcinoma of an
unreconstructed exstrophic bladder. Examination of the entire gastrointestinal tract shown there were not other
primary cites. Immunohistochemistry confirmed the nature of the tumour. The patient underwent a radical
cystoprostatectomy with en block bilateral pelvic lymphadenectomy, urinary diversion with a cutaneous
ureterostomy and epidpadias repair.
Conclusion: Adult bladder exstrophy and epispadia correction is a very rare practice in urology due the fact that
this congenital disease is diagnosed and corrected in neonates. We advocate the radical surgical management,
after exclusion of any primary malignant sites related to the gastrointestinal tract.
Background
Bladder exstrophy is a complex congenital abnormality
and its management is normally done in neonates.
Reports on exstrophy patients presenting in adulthood
are very rare. Bladder exstrophy occurs in approximately
1 in 35,000 live births and is associated with an increased
incidence of bladder cancer. Urinary bladder cancer is
the second most frequent tumour of the genitourinary
tract [1]. Adenocarcinomas of the bladder is an uncom-
mon malignant neoplasm and account for less than 2% of
all bladder cancers [2].
Few series have been reported in literature, but most
contain small numbers of cases.
One of the most common forms of adenocarcinoma of
the bladder is the metastatic adenocarcinoma. The pri-
mary sites for these tumours include the rectum, sto-
mach, endometrium, breast, prostate, and ovaries.
The reported incidence among exstrophy cohorts var-
ies from 3.3% to 7.5%, which is several times greater
than in age-matched controls in the general population
[3], [4].
In contrast, treatmentt of bladder exstrophy in
patients presenting in adulthood is rarely reported in
the literature [5], [6], [7], [8], [9]. Delayed presentation
may be due to lack of awareness, ignorance, social
embarrassment or even lack of appropriate facilities.
The etiology of this increased incidence remains
unclear. The environmental stimuli and chronic infec-
tion may cause bladder cells to undergo glandular meta-
plasia [10]. After excluding patients who underwent
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reconstruction, only around 113 cases of cancer occur-
ring in exstrophic bladders have been reported thus far.
Approximately 90% were adenocarcinomas and 5% were
squamous cell carcinomas[3], [4], [10], [11]. These can-
cers tend to be aggressive, and most patients undergo
radical cystectomy as primary therapy[3], [4].
There are a variety of histological types among adeno-
carcinomas, including papillary, glandular, adenoid cys-
tic, clear cell, mucinous and signet-ring cell carcinomas.
The last of these types is characterized by the presence
of intracellular vacuoles filled with mucin that displace
the hyperchromatic nuclei [12]. This patient was diag-
nosed with the mucinous and signet-ring cell subtypes
that is very rare and correspond to 20% of the bladder
adenocarcinoma [12],[13].
Methods
A 55-year-old man with classic bladder exstrophy who
had never undergone a reconstruction earlier presented
with a lesion of all his bladder [Figure 1]. The patient
was otherwise healthy. His renal function tests were
normal. The intravenous pyelogram showed bilateral
normal excretory kidneys with no cystogram phase. The
characteristic skeletal defects of exstrophy complex such
as widening of the pubic symphysis caused by malrota-
tion of the innominate bones in relation to the sagittal
plane of the body along both sacroiliac joints were pre-
sent. The metastatic work up was negative as seen on
the CT scan. No preoperative bladder biopsy were
performed.
We advocate the radical surgical management, after
exclusion of any primary malignant sites related to the
gastrointestinal tract.
The patient underwent radical cystectomy, closure of
the infra-umbelical defect with Cardiff repair with On-
lay mesh repair [14] and epispadias repair [Figure 3 - 4]
A wide local lymphadenectomy was performed [Figure 5].
Abdominal wall closure was done with a fasciocuta-
neous M-plasty [Figure 6 ].
Osteotomy was not done.
The orientation of the tumor on final clinical and
pathologic examination in our patient showed that the
bladder of 11x8 cm was completly occupied by a nodu-
lar, grey lesion of a maximum diameter of 10 cm produ-
cing mucin [Figure 2], thus strongly suggesting the
bladder as the primary source.
Results and discussion
Histopathological examination revealed a G3 poorly dif-
ferentiated (High grade) mucin-producing adenocarci-
noma, with intracellular and extracellular production of
mucin. The lymph nodes examinated were negative
showing a reactive lymphoid hyperplasia. The skin mar-
gins were not involved. The patient was not given any
adjuvant therapy and is doing well at six months of
follow-up.
Other primary sites for the tumor had been excluded
and, in the absence of digestive tract tumor and for con-
firmation that it was a primary bladder tumor, an
immunohistochemistry study was performed.
Regarding immunohistochemistry, adenocarcinoma of
the urinary bladder expresses CEA, CDX-2, MUC-1,
MUC-2 and MUC-3, same as colonic adenocarcinoma.
Cytokeratins 7 and 20 were positive, in contrast with
colonic adenocarcinoma that expresses cytokeratin 20
but not cytokeratin 7 [15].
Conclusions
Bladder exstrophy and epispadia is a very rare congeni-
tal disease in urology.
Because the vast majority of patients with bladder
exstrophy now undergo reconstruction at a young age,
unreconstructed bladder exstrophy in an adult patient is
exceedingly rare.
We advocate the radical surgical management, after
exclusion of any primary malignant sites related to the
gastrointestinal tract.
With proper surgical management of late presenting
bladder exstrophy patients, an acceptable functional and
cosmetic outcome can be achieved.
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